Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mefloquine Activity Against Urinary Schistosomiasis
NCT01132248Phase 2Completed
- Sponsor
- Albert Schweitzer Hospital
- Start
- May 2010
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mefloquine in urinary schistosomiasis, sponsored by Albert Schweitzer Hospital. Started May 2010; status: completed.
02
Drugs
mefloquine
03
Conditions
urinary schistosomiasis
Beyond the preview
Go deeper on NCT01132248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01132248.